4.Population pharmacokinetics and pharmacodynamics of clopidogrel in patients with acute coronary syndrome.
Cheng XIE ; Xiao-Liang DING ; Ling XUE ; Bin JIANG ; Yong-Fu HANG ; Jie GAO ; Li-Yan MIAO
Acta Pharmaceutica Sinica 2014;49(10):1426-1432
This study established a population pharmacokinetics-pharmacodynamics model of clopidogrel in patients with acute coronary syndrome. Fifty-nine patients were enrolled. The plasma concentration of clopidogrel active metabolite and vasodilator stimulated phosphoprotein platelet reactivity index (VASP-PRI) were selected as the pharmacokinetics index and the pharmacodynamics index, respectively. The covariates including demographic characteristics, laboratory indexes, combined medication, complications and genetic polymorphisms of related enzymes were screened for their influence on the pharmacokinetic and pharmacodynamics parameters. Population pharmacokinetic and pharmacodynamics data analysis was performed using NONMEM software. The general linear model and the indirectly effect model-turnover model for pharmacokinetic and pharmacodynamic analysis were selected as the basic model, respectively. The population typical values of K12, CL/F, V/F, EC50, K(in), and E(max) were 0.259 h(-1), 179 L x h(-1), 632 L, 1.57 ng x mL(-1), 4.29 and 0.664, respectively. CYP2C19 was the covariate in the final pharmacokinetic model, and the model was to design a prior dosage regimen.
Acute Coronary Syndrome
;
metabolism
;
Humans
;
Polymorphism, Genetic
;
Ticlopidine
;
analogs & derivatives
;
pharmacokinetics
5.Toxic epidermal necrolysis after percutaneous coronary intervention: which drug is the culprit?
Chinese Medical Journal 2011;124(3):467-468
Toxic epidermal necrolysis (TEN) is a serious, usually drug-induced, dermatosis characterized by extensive erythema, necrosis, bullous detachment of the epidermis, constitutional symptoms, and visceral involvement. We report a 62-year-old man who was diagnosed TEN after percutaneous coronary intervention (PCI). After consulting with a cardiologist, all pre-hospital medication was discontinued except clopidogrel. With supportive care, the patient recovered.
Angioplasty, Balloon, Coronary
;
Humans
;
Male
;
Middle Aged
;
Stevens-Johnson Syndrome
;
etiology
;
Ticlopidine
;
analogs & derivatives
;
therapeutic use
6.Impact of clopidogrel carboxylic metabolite SR26334 on gene expression profile of human umbilical vein endothelial cell line.
Xian-Feng LIU ; Xue-Chun LU ; Jian CAO ; Yan GAO ; Cong MA ; Yun LUO ; Li FAN
Journal of Experimental Hematology 2012;20(3):710-716
This study was purposed to characterize the effect of carboxylic acid metabolite (SR26334) of clopidogrel bisulfate deprived of antiplatelet efficacy on the spectrum of gene expression in the cultured human umbilical vein endothelial cell (HUVEC) line (EA.hy926), and to explore the potential molecule mechanism of SR26334 impact on HUVEC. By using a Affymetrix HU133 plus 2.0 oligonucleotide microarray, the alteration of gene expression spectrum induced by SR26334 in HUVEC was detected, the real-time PCR was used to confirm the results of selected differentially expressing genes. The results indicated that total 235 including 176 up-regulated and 59 down-regulated genes were obtained with change more than 1.5-fold after SR26334 (10 µmol/L) acted on HUVEC for 48 h. SR26334 affected the expression levels of genes involved regulation of transcription, transcription, positive regulation of transcription from RNA polymerase II promoter, cell cycle, cell division, protein amino acid dephosphorylation in HUVEC. It is concluded that carboxylic acid metabolite SR26334 of clopidogrel bisulfate modulates function of endothelial cells through different pathway at gene level.
Cell Line
;
Human Umbilical Vein Endothelial Cells
;
cytology
;
drug effects
;
Humans
;
Ticlopidine
;
analogs & derivatives
;
pharmacology
;
Transcriptome
;
drug effects
7.Evaluation of triple anti-platelet therapy by modified thrombelastography in patients with acute coronary syndrome.
Yi-hong REN ; Ting-shu YANG ; Yu WANG ; Lu-yue GAI ; Hong-bin LIU ; Lian CHEN ; Hong-ye WANG ; Chun-ya WANG ; Xiu-li XU ; Jing JIN ; You-hong XIN ; Rong-bin LI ; Hai-yan LI ; Lin LIN ; Chun-xue LIU
Chinese Medical Journal 2008;121(9):850-852
Acute Coronary Syndrome
;
drug therapy
;
Angioplasty, Balloon, Coronary
;
Aspirin
;
administration & dosage
;
Humans
;
Platelet Aggregation Inhibitors
;
administration & dosage
;
Thrombelastography
;
Ticlopidine
;
administration & dosage
;
analogs & derivatives
;
Tyrosine
;
administration & dosage
;
analogs & derivatives
8.Polymorphs of clopidogrel bisulfate.
Yi LIU ; Hai-Wei HUANG ; Jian-Min WU ; Ya-Qin SHI ; La-Hu YANG
Acta Pharmaceutica Sinica 2013;48(8):1358-1360
This paper is to report the polymorphism of raw materials of clopidogrel bisulfate at home and abroad. By the analysis of Fourier transform infrared spectroscopy (FTIR) and powder X-ray diffraction (p-XRD), samples are roughly classified into two groups, except one patent material. And the differential scanning calorimeter (DSC) examination showed more detailed information for these materials. The results of the study could provide comprehensive basis for the quality evaluation of clopidogrel bisulfate.
Calorimetry, Differential Scanning
;
Crystallization
;
Evaluation Studies as Topic
;
Platelet Aggregation Inhibitors
;
chemistry
;
Spectroscopy, Fourier Transform Infrared
;
Ticlopidine
;
analogs & derivatives
;
chemistry
;
X-Ray Diffraction
9.Impact of clopidogrel on gene profile of human umbilical vein endothelial cell line and bioinformatics analysis.
Xian-Feng LIU ; Xue-Chun LU ; Li FAN ; Yan GAO ; Cong MA ; Yun LUO
Journal of Experimental Hematology 2012;20(2):466-472
This study was purposed to investigate the effect of clopidogrel on gene expression profile of cultured human umbilical vein endothelial cell (HUVEC) line (EA.hy926), and explore its potential molecule mechanism. A Affymetrix U133 plus 2.0 oligonucleotide microarray was applied to detect the alteration of gene expression profile induced by clopidogrel in HUVEC. Real time RT-PCR was used to verify the result of selected differentially expressing genes. The results showed that total 508 genes (including 139 up-regulated and 369 down-regulated genes) were obtained with differential expression more than 1.5-fold after clopidogrel (10 µmol/L) acted on HUVEC for 48 h. Clopidogrel affected the expression levels of genes involved protein binding, transcription factor activity, zinc ion binding, regulation of DNA-dependent transcription, transcription, RNA splicing and so on. It is concluded that the clopidogrel modulate function of endothelial cells by regulating sets of genes through different pathway.
Cell Line
;
Human Umbilical Vein Endothelial Cells
;
drug effects
;
metabolism
;
Humans
;
Oligonucleotide Array Sequence Analysis
;
RNA, Messenger
;
genetics
;
Ticlopidine
;
analogs & derivatives
;
pharmacology
;
Transcription, Genetic
;
Transcriptome